Short facts

 

API

-

Technology

Digital therapeutics

Indication

Alcohol Use Disorder

Development phase

Registration with FDA in the US

Expected filing with FDA

See above

In-house or partnership

Partnership with GAIA AG

The Concept/Product

Vorvida® is a fully automated digital therapy developed by GAIA based on its proprietary artificial intelligence (AI)-expert system, broca®. Vorvida® is scientifically proven to reduce troublesome drinking patterns in adults with Alcohol Use Disorder.

Orexo owns the exclusive commercial rights for Vorvida® in the US.

Clinical Data

In a randomized controlled trial involving 608 adults with problematic alcohol intake, researchers found that participants in the intervention group with vorvida® significantly reduced their daily alcohol consumption over three and six months, with significant effect sizes.1 Additionally, in comparison to the control group, vorvida® users reported fewer days of binge drinking and drunkenness while stating high acceptance and utility rates of vorvida® at the same time.

 

1 Jördis M. Zill, Eva Christalle, Björn Meyer, Martin Härter, and Jörg Dirmaier The Effectiveness of an Internet Intervention Aimed at Reducing Alcohol Consumption in Adults: Results of a Randomized Controlled Trial (Vorvida) Dtsch Arztebl Int 2019; 116: 127–33. DOI: 10.3238/arztebl.2019.0127